SCALA, MARIA CARMINA
 Distribuzione geografica
Continente #
NA - Nord America 626
EU - Europa 183
AS - Asia 131
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 945
Nazione #
US - Stati Uniti d'America 622
IT - Italia 114
CN - Cina 62
VN - Vietnam 36
TR - Turchia 25
IE - Irlanda 23
UA - Ucraina 14
DE - Germania 12
SE - Svezia 7
IN - India 6
CZ - Repubblica Ceca 4
FR - Francia 4
MX - Messico 4
EU - Europa 3
GB - Regno Unito 2
RU - Federazione Russa 2
AU - Australia 1
FI - Finlandia 1
KR - Corea 1
PH - Filippine 1
UY - Uruguay 1
Totale 945
Città #
Chandler 125
Ann Arbor 107
Princeton 68
Salerno 50
Ashburn 47
Dong Ket 36
Houston 30
Woodbridge 27
Wilmington 26
Izmir 25
Dublin 23
Jacksonville 22
Beijing 15
Dearborn 14
Nanjing 10
Andover 9
Seattle 9
Guangzhou 8
Naples 8
Pellezzano 8
Redwood City 7
Boardman 6
Los Angeles 6
Shenyang 6
Cava de' Tirreni 5
Fairfield 5
Pune 5
Brno 4
Changsha 4
Norwalk 4
Tianjin 4
Agropoli 3
Fisciano 3
Nocera Superiore 3
Pomigliano D'arco 3
Aversa 2
Cadoneghe 2
Cerignola 2
Mercato San Severino 2
Munich 2
New York 2
Ningbo 2
Nürnberg 2
Rome 2
San Diego 2
San Jose 2
Washington 2
Acerra 1
Acton 1
Atlanta 1
Cambridge 1
Cergy 1
Chicago 1
Cuneo 1
Delhi 1
Frankfurt am Main 1
Fuzhou 1
Hebei 1
Helsinki 1
Jiaxing 1
Lanzhou 1
Manila 1
Melbourne 1
Montevideo 1
Nanchang 1
Napoli 1
Padova 1
Paris 1
Pompei 1
Pontecagnano 1
Shaoxing 1
Taizhou 1
Wuhan 1
Totale 785
Nome #
Antioxidant peptides released from gastrointestinal digestion of “Stracchino” soft cheese: Characterization, in vitro intestinal protection and bioavailability 120
Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor 84
Antioxidant properties of buffalo-milk dairy products: A β-Lg peptide released after gastrointestinal digestion of buffalo ricotta cheese reduces oxidative stress in intestinal epithelial cells 79
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization 65
LIPOSOMAL STRUCTURES DESIGN FOR PEPTIDE DELIVERY IN HEART FAILURE THERAPY 64
Design and synthesis of new cell penetrating peptides: Diffusion and distribution inside the cornea 64
Novel Potent Decameric Peptide of Spirulina platensis Reduces Blood Pressure Levels Through a PI3K/AKT/eNOS-Dependent Mechanism 60
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 53
On the design of tailored liposomes for KRX29 peptide delivery 51
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 44
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 38
Design, Synthesis, Biological Activity, and Structural Analysis of Lactam-Constrained PTPRJ Agonist Peptides 37
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 34
Synthesis and ex vivo trans-corneal permeation of penetratin analogues as ophthalmic carriers: Preliminary results 30
Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides 27
Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides 24
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 23
Peptide derivatives of the zonulin inhibitor larazotide (At1001) as potential anti sars cov-2: Molecular modelling, synthesis and bioactivity evaluation 22
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2 21
In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate 19
Short-length derivatives of cell-penetrating peptides for ocular drug delivery 11
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 10
Antiviral Peptides as Anti-Influenza Agents 7
Structure-Based Development of SARS-CoV-2 Spike Interactors 3
Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides 3
Totale 993
Categoria #
all - tutte 3.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 0 41 2
2019/2020105 24 6 8 4 3 6 0 5 0 24 17 8
2020/202193 2 1 1 1 5 4 8 2 25 2 4 38
2021/2022119 0 1 0 3 12 1 1 3 14 14 20 50
2022/2023244 20 40 4 51 17 49 1 22 24 2 9 5
2023/2024157 12 12 7 16 12 40 11 20 13 14 0 0
Totale 993